Sign inJoin waitlistJoin the waitlist

Back to University of Michigan Internal Medicine

Kevin R Flaherty

IRB Vice Chair and Associate Residency Program Director, Internal Medicine Residency · University of Michigan Health-Ann Arbor

Credentials: ·

History

Internal Medicine Residency · University of Michigan Health-Ann Arbor
Present

Research

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management
American Journal of Respiratory and Critical Care Medicine · 2011 · 5,726 citations
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis
New England Journal of Medicine · 2014 · 3,674 citations
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias
American Journal of Respiratory and Critical Care Medicine · 2013 · 3,318 citations

Fernando Martinez
135 papers
Kevin Brown
59 papers
Ganesh Raghu
54 papers
Ella Kazerooni
43 papers
GT
Galen Toews
30 papers
Imre Noth
29 papers
Jeffrey Myers
29 papers
TC
Thomas Colby
29 papers
WT
William Travis
28 papers
David Lynch
26 papers
Harold Collard
26 papers
BG
Barry Gross
25 papers

Grants

Prospective tReatment EffiCacy in IPF uSlng genOtype for Nac Selection (PRECISIONS) Trial and Molecular Endophenotyping in Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases Study
National Heart, Lung, and Blood Institute · U24
PI · $6.6M · University of Michigan at Ann Arbor
2019–2027
Short Term Biomedical Research Training Program for Students
National Heart, Lung, and Blood Institute · T35
Contact PI · $102.3K · University of Michigan at Ann Arbor
1980–2025
Forging a Road to Personalized Medicine in Interstitial Lung Diseases
National Heart, Lung, and Blood Institute · K24
Contact PI · $908.8K · University of Michigan at Ann Arbor
2012–2018
Longitudinal, Computer Assisted Analysis in IPF
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.6M · University of Michigan at Ann Arbor
2008–2014

Clinical trials

Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial
Principal investigator · Completed · Phase 3
Fernando J Martinez
2020–2026
Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)
Principal investigator · Completed
University of Michigan
2009–2012
Safety Study of Tetrathiomolybdate in Patients With Idiopathic Pulmonary Fibrosis
Principal investigator · Completed · Phase 1, Phase 2
University of Michigan
2003–2006
Pulmonary Fibrosis Foundation Patient Registry
Study chair · Completed
Pulmonary Fibrosis Foundation
2016–2022